Toggle Main Menu Toggle Search

Open Access padlockePrints

Recipient NOD2/CARD15 Variants: A Novel Independent Risk Factor for the Development of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation

Lookup NU author(s): Professor Anne Dickinson

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Bronchiolitis obliterans (BO) is a serious complication after allogeneic stem cell transplantation. We hypothesized that single nucleotide polymorphisms (SNPs) of the NOD2/CARD15 gene (= NOD2/CARD15 variants) contribute to changes in host defense and subsequent alloreaction, leading to BO. We analyzed 427 donor-recipient pairs for the association of NOD2/CARD15 variants (SNP8 [Arg702Trp], SNP12 [Gly908Arg], and SNP13 [Leu1007fsinsC]) with BO occurrence. Overall, 11 patients (2.6%) developed BO. The cumulative incidence of BO rose from 1.3% in donor-recipient pairs without mutation to 18.7% in pairs with donor or recipient NOD2/CARD15 variants (P < .001). Recipient NOD2/CARD15 variants alone led to BO in 22.3% (P < .001), whereas donor variants alone associated with BO in 13.2% (P = .04). Multivariate analysis proved recipient but not donor NOD2/CARD15 variants to be a novel independent risk factor for BO development, and NOD2/CARD15 typing may help identify patients at increased risk for BO. © 2008 American Society for Blood and Marrow Transplantation.


Publication metadata

Author(s): Hildebrandt GC, Granell M, Urbano-Ispizua A, Wolff D, Hertenstein B, Greinix HT, Brenmoehl J, Schulz C, Dickinson AM, Hahn J, Rogler G, Andreesen R, Holler E

Publication type: Article

Publication status: Published

Journal: Biology of Blood and Marrow Transplantation

Year: 2008

Volume: 14

Issue: 1

Pages: 67-74

ISSN (print): 1083-8791

ISSN (electronic): 1523-6536

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/j.bbmt.2007.09.009

DOI: 10.1016/j.bbmt.2007.09.009

PubMed id: 18158963


Altmetrics

Altmetrics provided by Altmetric


Share